HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
about
Hypersensitivity reactions to HIV therapy.Epidemiology and risk factors for drug allergy.Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects.N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo.HLA alleles and drug hypersensitivity reactions.HLA and pharmacogenetics of drug hypersensitivity.The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods.Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.Direct PCR: a new pharmacogenetic approach for the inexpensive testing of HLA-B*57:01.
P2860
Q34976463-E6CB7159-D982-44B7-96AB-2B4B55F357D0Q34976470-95B9F13C-AB98-4112-81F3-3D789574A018Q35233168-2A4522E6-207A-4050-8A87-24D19725C60FQ36343650-954F8566-3B41-483E-932B-B20D6EA8C11EQ36419326-FAF826FF-32B5-4F9A-896C-593BE65F2A78Q37963995-85E9334F-91B9-46F7-A4F0-9E53C2F26514Q38037649-D9F50E78-5D16-4152-BD73-E9F771BC1CB5Q38064446-E0B3059A-A21A-4DDF-99E9-96F676B979F4Q38080040-A16DF6A2-9CA5-4016-B9E7-4B107335605FQ41747771-E9AF0BBC-7077-4489-8178-E7CC308E9B70
P2860
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@en
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@nl
type
label
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@en
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@nl
prefLabel
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@en
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@nl
P2860
P1476
HLA-B*5701 screening prior to abacavir prescription: clinical and laboratory aspects.
@en
P2093
David Nolan
P2860
P304
P356
10.1080/10408360902937817
P577
2009-01-01T00:00:00Z